Vitamin D Binding Protein-Macrophage Activating Factor Inhibits HCC in SCID Mice
Authors:
- 1 September 2010
- journal article
- Published by Elsevier in Journal of Surgical Research
- Vol. 172 (1) , 116-122
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- The epidemiology of hepatocellular cancer: from the perspectives of public health problem to tumor biologyJournal of Gastroenterology, 2009
- Current management strategy of hepatocellular carcinomaWorld Journal of Gastroenterology, 2009
- Tumor-infiltrating macrophages can predict favorable prognosis in hepatocellular carcinoma after resectionJournal of Cancer Research and Clinical Oncology, 2008
- Phase II Trial Evaluating the Clinical and Biologic Effects of Bevacizumab in Unresectable Hepatocellular CarcinomaJournal of Clinical Oncology, 2008
- Role of transplantation in the management of hepatic malignancyBritish Journal of Surgery, 2007
- Macrophage activation increases the invasive properties of hepatoma cells by destabilization of the adherens junctionFEBS Letters, 2006
- Microvessel density and clinicopathological characteristics in hepatitis C virus and hepatitis B virus related hepatocellular carcinomaJournal of Clinical Pathology, 2004
- Pancreatic CarcinogenesisPancreas, 2004
- Effects of Vitamin D3-Binding Protein-Derived Macrophage Activating Factor (GcMAF) on AngiogenesisJNCI: Journal of the National Cancer Institute, 2002
- Tumor Angiogenesis: Therapeutic ImplicationsNew England Journal of Medicine, 1971